Tackling Biofilm-Forming Pathogens: A Challenge to Overcome in the Fight Against Infectious Diseases

Area of Science:

• Microbiology
• Infectious Diseases
• Biotechnology

Background:

• Microorganisms form structured biofilms, encased in exopolysaccharides, acting as protective barriers.
• Biofilms are crucial in bacterial virulence, antimicrobial resistance, and persistent infections, complicating treatment.
• Biofilm formation is a dynamic process regulated by quorum sensing and influenced by environmental factors.

Purpose of the Study:

• To review the clinical significance of biofilms in infectious disease pathogenesis.
• To highlight biofilm-associated infections, particularly those linked to medical devices and specific pathogens.
• To examine strategies for combating antibiotic resistance in biofilms and address diagnostic challenges.

Main Methods:

• Literature review focusing on biofilm formation, pathogenesis, and clinical implications.
• Analysis of prevalent pathogens involved in biofilm-related infections (e.g., S. aureus, P. aeruginosa, Candida species).
• Examination of current and emerging therapeutic strategies against bacterial biofilms.

Main Results:

• Biofilms significantly impede antimicrobial efficacy and immune responses, fostering chronic and device-associated infections.
• Key pathogens like S. aureus, P. aeruginosa, and E. coli are frequently implicated in biofilm infections.
• Antibiotic resistance is a major challenge, necessitating novel approaches to disrupt biofilm integrity.

Conclusions:

• Biofilms represent a critical challenge in clinical settings, contributing to treatment failure and persistent infections.
• Understanding biofilm pathogenesis is essential for developing effective diagnostic and therapeutic interventions.
• New strategies targeting biofilm disruption are crucial for overcoming antibiotic resistance and improving patient outcomes.